tlooto
LoginSign up

Disparities in mortality among HER2-positive breast cancer patients treated with trastuzumab in Chile (2015–2024): real-world evidence from 4,920 cases

Yanara A. Bernal, Allison Landeros-Contreras, Edgardo Rojas-Mancilla, Carla Campaña, Iris Delgado, Karen Y. Oróstica, Ricardo Armisén

2026.7.15FUTURE ONCOLOGY

DOI: 10.1080/14796694.2026.2695216

Abstract

Abstract is not available.

Citation format

BERNAL, Yanara A., et al. Disparities in mortality among her2-positive breast cancer patients treated with trastuzumab in chile (2015–2024): Real-world evidence from 4,920 cases. FUTURE ONCOLOGY, 2026.